S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

US Crude Stocks Rise 3.4 Million Barrels

U.S. commercial crude inventories rose by 3.4 million barrels in the week ending November 13, reaching 417.8 million barrels, the Energy Information Administration said Wednesday. Stocks remained 3% below the five-year average for this time of year, while total commercial petroleum inventories climbed by 9.2 million barrels.

US Crude Stocks Rise 3.4 Million Barrels

The EIA’s report followed figures from the American Petroleum Institute released a day earlier, which showed a 5.3 million-barrel increase in crude inventories.

At 9:57 a.m. in New York on Wednesday, Brent futures were down $1.21, or 1.44%, at $91.93 a barrel and had fallen $1.30 over the week. West Texas Intermediate was down $1.70, or 1.98%, at $84.31 a barrel, roughly $2 lower than the previous Wednesday.

Gasoline inventories rose by 5.2 million barrels after increasing by 1.8 million barrels the previous week. Average daily gasoline production fell to 9.4 million barrels. Middle distillate stocks increased by 1.6 million barrels, while production averaged 5.2 million barrels a day. Distillate inventories were 7% below their five-year average.

Total products supplied, an indicator of U.S. oil demand, averaged 20.6 million barrels per day over the latest four weeks, down 0.3% from the same period a year earlier. Gasoline supplied averaged 8.7 million barrels per day. The four-week average for distillates was 4.0 million barrels per day, up 4.3% year over year.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!